Drugs - Real World Outcomes Q2 Unclaimed
Springer International Publishing AG
Switzerland
Drugs - Real World Outcomes is a journal indexed in SJR in Pharmacology (medical) with an H index of 24. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2090 €. The scope of the journal is focused on big data, drug utilization, treatment guideline adherence, patient behaviour, real world healthcare. It has an SJR impact factor of 0,673 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,673.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Pharmacology (medical) (Q2)
Price
2090 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,673
SJR Impact factor24
H Index67
Total Docs (Last Year)173
Total Docs (3 years)2263
Total Refs362
Total Cites (3 years)173
Citable Docs (3 years)2.08
Cites/Doc (2 years)33.78
Ref/DocOther journals with similar parameters
AIDS Research and Therapy Q2
Drug Safety - Case Reports Q2
Expert Review of Anticancer Therapy Q2
Trials Q2
American Journal of Cardiovascular Drugs Q2
Compare this journals
Aims and Scope
Big data
Drug utilization
Treatment guideline adherence
Patient behaviour
Real world healthcare
Comments